FEATURE ARTICLE
Transformation of Arenes into Substituted Cyclohexadienes
2049
MS: m/z (%) 376 (6), 326 (8), 216 (83), 201 (32), 131 (100), 103
IR (CH2Cl2): 3077w, 3040w, 2960vs, 1947m, 2905m, 2870m,
(71), 73 (95).
1650m, 1612vs, 1573w, 1479m, 1403w, 1363m, 1348m, 1334m,
1300m, 1240m, 1210w, 1014m, 981m, 960m, 917m cm-1.
HR-MS: m/z calcd for C20H19NOSi: 327.2018. Found: 327.2014.
1H NMR (CDCl3, 400 MHz): = 0.89 (s, 9 H), 1.03 (d, 3 H, J = 7.3
Hz), 1.89-2.03 (m, 1 H), 2.07-2.17 (m, 2 H), 2.87 (q, 1 H, J = 7.3
Hz), 3.91 (dd, 1 H, J = 6.7, 10.0 Hz), 4.08–4.18 (m, 2 H), 4.91–5.03
(m, 2 H), 5.69–5.80 (m, 1 H), 5.94 (dd, 1 H, J = 5.5, 9.6 Hz), 5.99
(dd, 1 H, J = 5.1, 9.6 Hz), 6.56 (d, 1 H, J = 5.1 Hz).
(4S)-4-Isopropyl-2-[(5R,6S)-6-methyl-5-(3-trimethylsilanyl-
prop-2-ynyl)-cyclohexa-1,3-dienyl]-4,5-dihydro-oxazole (15a)
The reaction was carried out in THF as described for 10a with MeLi
on a scale of 1.0 mmol of 3a. HMPA (1.74 mL, 10 equiv) was added
immediately prior to the addition of trimethylsilyl propargyl bro-
mide. GC analysis (initial T: 100 °C; initial time: 5 min; 10 °C/min;
major diastereoisomer 15a (19.6 min); minor diastereoisomer 15b
(19.8 min)) showed the formation of two products in the ratio of 93:
7. Purification by flash chromatogaraphy (hexane Et2O, 7:1 to 5:1)
afforded the mixture of diasteroisomers (242.9 mg, 77%).
MS: m/z (%) 259 (20), 218 (100), 202 (68), 160 (40), 146 (20), 119
(50), 110 (20), 91 (30), 86 (65), 84 (100).
HR-MS: m/z calcd. for C17H25NO: 259.1936. Found: 259.1917.
(–)-(4S)-2-[(5R,6S)-5-Allyl-6-butyl-cyclohexa-1,3-dienyl]-4-
tert-butyl-4,5-dihydro-oxazole (18a)
The reaction was carried out in THF (10 mL) with complex 3b
(339.3 mg, 1.0 mmol), BuLi and allylbromide. The procedure used
was that described for 11a. HPLC analysis showed the formation of
a single diastereoisomer. Flash chromatography (hexane–Et2O, 5:1)
afforded 18a (192.9 mg, 62%).
15a
[ ]20 –301.6 (c 0.98, CHCl3)
D
IR (CH2Cl2): 3042w, 2961vs, 2927m, 2900m, 2873m, 2171m,
1651m, 1612s, 1574m, 1467m, 1425m, 1044m, 1386m, 1364m,
1345m, 1301m, 1274s, 1252s, 1048m, 1019m, 973m, 909m, 845vs
cm-1.
[ ]20D –443.2 (c 1.09, CHCl3).
1H NMR (CDCl3, 200 MHz): = 0.13 (s, 9 H), 0.85 (d, 3 H, J = 6.8
Hz), 0.95 (d, 3 H, J = 6.8 Hz), 1.06 (d, 3 H, J = 7.1 Hz), 1.75–1.95
(m, 1 H), 2.05–2.35 (m, 3 H), 2.94 (q, 1 H, J = 7.1 Hz), 3.95–4.30
(m, 3 H), 5.96–6.10 (m, 2 H), 6.54–6.62 (m, 1 H).
IR (CH2Cl2): 3077w, 3039w, 2958vs, 2931s, 2870m, 1649m,
1613s, 1479m, 1462m, 1442m, 1364m, 1352m, 1354m, 1299m,
1027m, 960m, 917m cm-1.
1H NMR (CDCl3, 400 MHz): = 0.86 (m, 3 H), 0.88 (s, 9 H), 1.18–
1.50 (m, 6 H), 1.92–2.02 (m, 1 H), 2.07–2.17 (m, 1 H) 2.23–2.32 (m,
1 H), 2.73–2.80 (m, 1 H), 3.90 (dd, 1 H, J = 7.0, 10.0 Hz), 4.07 (dd,
1 H, J = 7.0 Hz), 4.15 (dd, 1 H, J = 7.0, 10.0 Hz), 4.93–5.04 (m, 2
H), 5.70–5.80 (m, 1 H), 5.91 (dd, 1 H, J = 5.5, 9.1 Hz), 5.98 (dd, 1
H, J = 5.5, 9.1 Hz), 6.58 (d, 1 H, J = 5.5 Hz).
MS: m/z (%) 315 (10), 300 (4), 272 (5), 204 (80), 160 (21), 119
(100), 91 (78), 73 (40), 59 (11).
HR-MS: m/z calcd for C19H29NOSi: 315.2018. Found: 315.2002.
(-)-(4S)-2-[(5R,6S)-5-Benzyl-6-methyl-cyclohexa-1,3-dienyl]-4-
isopropyl-4,5-dihydro-oxazole (16a)
MS: m/z (%) 301 (20), 260 (100), 244 (30), 204 (30), 161 (23), 146
(32), 105 (30), 91 (31), 86 (64), 84 (100).
The reaction was carried out as described for 10a with methyl lith-
ium and benzylbromide on a scale of 1.00 mmol of 3a in THF. GC
analysis (initial T: 150 °C; initial time: 5 min; 25 °C/min; major di-
astereoisomer 16a (12.4 min); minor diastereoisomer 16b (13.0
min)) showed the formation of two products in the ratio of 95:5. Pu-
rification by flash chromatography (hexane-Et2O, 5:1) afforded the
mixture of diastereomisomers (150.6 mg, 51%). A sample of pure
16a was obtained by preparative HPLC (Silica spheri 5 mm,
250 10 mm column; hexane EtOAc, 20:1, 5mL/min).
HR-MS: m/z calcd for C20H31NO 301.2405. Found: 301.2384.
(–)-(4S)-2-[(5R,6S)-5-Allyl-6-phenyl-cyclohexa-1,3-dienyl]-4-
tert-butyl-4,5-dihydro-oxazole (19a) and (4S)-2-[(5S,6R)-5-
Allyl-6-phenyl-cyclohexa-1,3-dienyl]-4-tert-butyl-4,5-dihydro-
oxazole (19b)
The procedure followed was analogous to that described for 13 us-
ing complex 3b in place of 3a (1 mmol scale, THF toluene, 1:5, 48
mL), PhLi and allylbromide. HPLC analysis (hexane–EtOAc, 20:1,
5 mL/min, major 4.6 min, minor 6.0 min) showed two products in
the ratio of 92:8. Flash chromatography (hexane Et2O, 6:1) afford-
ed 19a (164 mg, 51%) and 19b (9.0 mg, 3%).
[ ]20 –440.7 (c 4.19, CHCl3).
D
IR (CH2Cl2): 3085w, 3070w, 3060w, 3055m, 3050m, 3035m,
2965vs, 2930s, 2905s, 2875s, 1052s, 1611vs, 1574w, 1496m,
1481w, 1467m, 1455m, 1407w, 1385w, 1363m, 1348m, 1304w,
1281w, 1274w, 1266w, 1240m, 1048s, 1022s, 974m cm-1.
1H NMR (CDCl3, 400 MHz): = 0.92 (d, 3 H, J = 6.8 Hz), 0.97 (d,
3 H, J = 7.2 Hz), 0.99 (d, 3 H, J = 6.8 Hz), 1.83–1.93 (m, 1 H),
2.27–2.34 (m, 1 H), 2.45 (dd, 1 H, J = 9.0, 13.0 Hz), 2.67 (dd, 1 H,
J = 7.0, 13.0 Hz), 2.81 (bq, 1 H, J = 7.2 Hz), 3.98–4.10 and 4.20–
4.25 (m, 3 H), 5.92 (dd, 1 H, J = 5.6, 9.2Hz), 6.03 (dd, 1 H, J = 5.6,
9.2Hz), 6.63 (d, 1 H, J = 5.2 Hz), 7.10–7.28 (m, 5 H).
19a
[ ]20D –484.1 (c 0.755, CHCl3).
IR (CH2Cl2): 3080w, 3040w, 3027w, 2960s, 2905m, 2873m,
1650m, 1615vs, 1492m, 1452m, 1403m, 1364m, 1350m, 1300m,
1230m, 1050m, 1030m, 960m, 919m cm-1.
1H NMR (CDCl3, 200 MHz): = 0.85 (s, 9 H), 2.06–2.35 (m, 2 H),
2.40–2.54 (m, 1 H), 3.80 (dd, 1 H, J = 7.5, 10 Hz), 3.98–4.17 (m, 3
H), 5.00–5.16 (m, 2 H), 5.64–5.95 (m, 2 H), 6.11 (dd, 1 H, J = 6.0,
10.0 Hz), 6.91 (d, 1 H, J = 5.5 Hz), 7.10–7.30 (m, 5 H).
MS: m/z (%) 296 (M+1, 3), 252 (1), 204 (31), 160 (26), 119 (90), 91
(100).
HR-MS: m/z calcd for C20H25NO: 295.1936. Found: 295.1915.
MS: m/z (%) 321 (5), 280 (100), 264 (35), 260 (38), 244 (15), 238
(15) 222 (25), 181 (40). HR-MS: m/z calcd for C22H27NO:
321.2092. Found: 321.2071.
(–)-(4S)-2-((5R,6S)-5-Allyl-6-methyl-cyclohexa-1,3-dienyl)-4-
tert-butyl-4,5-dihydro-oxazole (17a)
The reaction was carried out exactly as that described for 10a using
complex 3b in place of 3a, MeLi and allylbromide HPLC analysis
showed the formation of a single diastereoisomer. Flash chromatog-
raphy (hexane Et2O, 8:1) afforded 17a (149.4 mg, 58%).
19b
1H NMR (CDCl3, 200 MHz): = 0.56 (s, 9 H), 2.20–2.35 (m, 2 H),
2.46–2.58 (m, 1 H), 3.83 (dd, 1 H, J = 6.0,10.0 Hz), 3.96–4.10 (m,
3 H), 5.00–5.12 (m, 2 H), 5.77–6.00 (m, 2 H), 6.12 (dd, 1 H, J = 6.0,
10.0 Hz), 6.86 (d, 1 H, J = 6.0 Hz), 7.10–7.30 (m, 5 H).
[ ]20D –512.4 (c 0.835, CHCl3).
Synthesis 2001, No. 13, 2040–2054 ISSN 0039-7881 © Thieme Stuttgart · New York